Skip to content

The effectiveness of mandala coloring on anxiety, stress and depression in patients with multiple sclerosis

The effectiveness of mandala coloring on anxiety, stress and depression in patients with multiple sclerosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240609062057N1
Enrollment
64
Registered
2024-06-22
Start date
2024-06-21
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention Group: In the intervention group, a Mandala design is provided 6 days a week, and individuals are asked to color it for 30 minutes each time per day (coloring is done at t
also, the researcher's contact information is provided to participants so that individuals can communicate with the researcher through virtual space after completing the paintings if necessary (22). O

Sponsors

Khomein University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmation of the disease according to the neurologist's diagnosis Age over 18 years, history of illness for at least 6 months Not suffering from another acute or chronic disease ability to speak (speech and hearing), Not having dementia and known mental disorders confirmed by a doctor Consent to participate in the research Literacy at least reading and writing

Exclusion criteria

Exclusion criteria: Lack of consent to participate in the research Dementia and known mental disorders confirmed by a doctor Age less than 18 years Having another acute or chronic disease

Design outcomes

Primary

MeasureTime frame
Anxiety, stress and depressionAnxiety, stress and depression scores in the relevant questionnaires. Timepoint: It examines three scales of depression, anxiety, and stress. The outcomes assessed in this research will be measured once before the intervention and once at the end of the intervention and after 6 days. Method of measurement: DASS21 test made by Lovibond.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Etedali

Khomein University of Medical Sciences

masoud.etedali@khomeinums.ac.ir+98 937 914 6943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026